FDA Clears Wandercraft's Exoskeleton for Rehabilitation of Stroke Patients

FDA Clears Wandercraft’s Exoskeleton for Rehabilitation of Stroke Patients

Stroke victims in the United States may soon be able to benefit from cutting-edge robotics throughout their rehabilitation. Wandercraft’s Atalante exoskeleton has been certified for use in stroke therapy by the Food and Drug Administration. The machine may aid in intense gait training, especially for persons with restricted upper body movement who may be unable to use conventional approaches.